This trial is testing a drug to treat pancreatic cancer that cannot be removed by surgery. The drug may help patients live longer.
- Pancreatic Cancer
- Stage I Pancreatic Cancer
- Stage IIB Pancreatic Cancer
- Stage IA Pancreatic Cancer
- Stage 0 Pancreatic Cancer
- Stage IB Pancreatic Cancer
- Stage II Pancreatic Cancer
- Stage IIA Pancreatic Cancer
1 Primary · 3 Secondary · Reporting Duration: Up to 30 days from last dose
Awards & Highlights
1 Treatment Group
Treatment (pyrvinium pamoate)
1 of 1
18 Total Participants · 1 Treatment Group
Primary Treatment: Pyrvinium Pamoate · No Placebo Group · Phase 1
Who is running the clinical trial?
Age 18+ · All Participants · 1 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
Frequently Asked Questions
Does Pyrvinium Pamoate have any harmful side effects?
"Given that this is a Phase 1 trial with limited data surrounding its safety and efficacy, our team at Power has given Pyrvinium Pamoate a score of 1." - Anonymous Online Contributor
Is there a significant body of scientific research on Pyrvinium Pamoate?
"At the moment, there is only 1 active clinical trial for Pyrvinium Pamoate. This is a Phase 3 trial. The majority of research surrounding Pyrvinium Pamoate is conducted in Philadelphia, with 1 other location running similar studies." - Anonymous Online Contributor